
MEOBF
Healthcare · Biotechnology · $1.48B market cap
$1.140.00 (0.0%)Nov 13, 9:30 AM EST
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Sep 30, 2026
EPS trend, 90 days to now
Beat estimates in 3 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| May 29, 2026 | Time not confirmed | -0.01 | 0.00 | +100.0% |
| Nov 26, 2025 | Time not confirmed | -0.01 | -0.01 | +30.0% |
| Aug 28, 2025 | After the close | -0.04 | -0.04 | 0.0% |
| May 30, 2025 | Time not confirmed | -0.01 | 0.00 | +100.0% |
| Feb 26, 2025 | Time not confirmed | -0.01 | -0.04 | -166.7% |
| Nov 20, 2024 | Time not confirmed | -0.01 | -0.01 | -7.7% |
| Aug 28, 2024 | Time not confirmed | -0.03 | 0.00 | +100.0% |
| May 29, 2024 | Time not confirmed | -0.02 | 0.00 | +100.0% |
| Feb 29, 2024 | Before the open | -0.02 | -0.02 | -7.5% |
| Nov 22, 2023 | Time not confirmed | -0.03 | -0.03 | +12.3% |
| Aug 30, 2023 | Time not confirmed | -0.03 | -0.03 | +6.7% |
| May 25, 2023 | Time not confirmed | -0.02 | -0.03 | -26.5% |
| Feb 27, 2023 | Time not confirmed |
Mesoblast Limited, together with its subsidiaries, engages in the development of regenerative medicine products in Australia. The company's proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage cells. It offers Ryoncil for the treatment of systemic inflammatory diseases, including steroid refractory acute graft versus host disease, Duchenne muscular…
| -0.03 |
| -0.03 |
| -10.7% |
| Nov 22, 2022 | Time not confirmed | -0.02 | -0.02 | -21.5% |
| Aug 30, 2022 | Time not confirmed | -0.03 | -0.03 | -13.3% |
| May 31, 2022 | Time not confirmed | -0.03 | -0.03 | -9.3% |
| Feb 24, 2022 | Time not confirmed | -0.04 | -0.04 | 0.0% |
| Oct 28, 2021 | Time not confirmed | -0.03 | -0.03 | -16.3% |
| Aug 30, 2021 | Time not confirmed | -0.03 | -0.03 | -6.7% |
| Jun 2, 2021 | Time not confirmed | -0.04 | -0.04 | -9.8% |
| Feb 26, 2021 | Time not confirmed | -0.04 | -0.04 | -9.5% |
| Nov 19, 2020 | Time not confirmed | -0.04 | -0.04 | -5.3% |
| Aug 26, 2020 | Time not confirmed | -0.05 | -0.06 | -20.0% |
| May 27, 2020 | Time not confirmed | -0.03 | -0.03 | +5.3% |
| Feb 26, 2020 | Time not confirmed | -0.04 | -0.05 | -15.0% |
| Nov 25, 2019 | Time not confirmed | -0.01 | -0.01 | -10.0% |
| Aug 29, 2019 | Time not confirmed | -0.04 | -0.04 | -5.0% |
| May 30, 2019 | Time not confirmed | -0.05 | -0.05 | 0.0% |
| Feb 20, 2019 | Time not confirmed | -0.05 | -0.05 | 0.0% |
| Nov 15, 2018 | Time not confirmed | -0.05 | -0.04 | +18.6% |
| Aug 29, 2018 | Time not confirmed | -0.05 | -0.04 | +12.0% |
| May 30, 2018 | Time not confirmed | -0.04 | -0.04 | -11.8% |
| Feb 27, 2018 | Time not confirmed | — | 0.03 | — |